SHA:600196 Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 9.88B CNY in the quarter ending September 30, 2025, a decrease of -5.46%. This brings the company's revenue in the last twelve months to 39.55B, down -4.96% year-over-year. In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B, down -0.80%.

Revenue (ttm)

39.55B

Revenue Growth

-4.96%

P/S Ratio

1.60

Revenue / Employee

975.14K

Employees

40,234

Market Cap

63.31B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.07B	-332.34M	-0.80%
Dec 31, 2023	41.40B	-2.55B	-5.81%
Dec 31, 2022	43.95B	4.94B	12.66%
Dec 31, 2021	39.01B	8.70B	28.72%
Dec 31, 2020	30.31B	1.72B	6.02%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Huadong Medicine	43.09B
Shenzhen Salubris Pharmaceuticals	4.25B
China Resources Sanjiu Medical & Pharmaceutical	31.63B
Beijing Tongrentang	18.09B
Yunnan Baiyao Group Co.,Ltd	40.77B
Sichuan Biokin Pharmaceutical	2.52B
Changchun High-Tech Industry (Group)	12.88B
Zhejiang NHU Company	22.47B

Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

2 years ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
3 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
5 years ago - Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations - CNBC

More News